Relationship between low levels of high-density lipoprotein cholesterol and dementia in the elderly. the inchianti study

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 65 A, Issue 5, 2010, Pages 559-564

  Zuliani, G ^a,g   Cavalieri, M ^a   Galvani, M ^a   Volpato, S ^a   Cherubini, A ^b   Bandinelli, S ^d   Corsi, A M ^d   Lauretani, F ^e   Guralnik, J M ^f   Fellin, R ^a,g   Ferrucci, L ^c,f  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c ASF Geriatric Rehabilitation   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

^e UNIVERSITY HOSPITAL OF PARMA   (Italy)

^f NATIONAL INSTITUTE ON AGING   (United States)

^g Ctro E Malattia Alzheimer Perusini   (Italy)

Author keywords

Dementia; Elderly; Lipids

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

AGE; AGED; ANKLE BRACHIAL INDEX; ARTICLE; BLOOD; DEMENTIA; EDUCATIONAL STATUS; FEMALE; GENETIC POLYMORPHISM; GENETICS; HUMAN; ITALY; MALE; MULTIVARIATE ANALYSIS; NONPARAMETRIC TEST; PREVALENCE; PSYCHOLOGIC TEST; RISK FACTOR; SEX DIFFERENCE; STATISTICAL MODEL;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANKLE BRACHIAL INDEX; APOLIPOPROTEINS E; CHOLESTEROL; CHOLESTEROL, HDL; DEMENTIA; EDUCATIONAL STATUS; FEMALE; HUMANS; ITALY; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; POLYMORPHISM, GENETIC; PREVALENCE; PSYCHOLOGICAL TESTS; RISK FACTORS; SEX FACTORS; STATISTICS, NONPARAMETRIC;

EID: 77951916345     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glq026     Document Type: Article

References (41)

1. Kivipelto M, Helkala EL, Laaskom P, et al. Midlife vascular risk factors and alzheimer's disease in later life: longitudinal Population based study. BMJ. 2001, 322, 1447-1451.
2. Hofman A, Ott A, Breteler MMB, et al. Atherosclerosis, Apolipopro-tein E, and prevalence of dementia and alzheimer's disease in the Rotterdam Study. Lancet. 1997;349:151-154. (Pubitemid 27039193)
3. Kalmijn S, Foley D, White L, et al. Metabolic cardiovascular syndrome and risk of dementia in Japanese-american elderly men. The Honolulu-asia aging study. Arterioscler Thromb Vasc Biol. 2000;20:2255-2260.
4. Tan ZS, Seshadri S, Beiser A, et al. Plasma total cholesterol level as a risk factor for alzheimer's disease: the Framingham Study. Arch Intern Med. 2003;163:1053-1057.
5. Kuusisto J, Koivisto K, Mykkanen L, et al. Association between features of the insulin resistance syndrome and alzheimer's disease independently of apolipoprotein e4 phenotype: cross sectional population based study. BMJ. 1997;315:1045-1049.
6. Siest G, Bertrand P, Qin B, et al. Apolipoprotein e polymorphism and serum concentration in alzheimer' disease in nine european centers: the apoeurope study. Apoeurope Group. Clin Chem Lab Med. 2000; 38:721-730.
7. Czyzewski K, Lalowski MM, Pfeffer A, Barcikowska M. Lipid metabolism parameters in patients with alzheimer's disease and their frst degree relatives. Acta Neurobiol Exp. 2001;61:21-26.
8. Kim JM, Stewart R, Shin IS, Yoon JS. Low cholesterol, Cognitive function and alzheimer's disease in a community population with cognitive impairment. J Nutr Health Aging. 2002;6:320-323.
9. Romas SN, Tang MX, Berglund L, Mayeux R. APOe genotype, Plasma lipids, Lipoproteins, and aD in community elderly. Neurology. 1999;53:517-521.
10. Reitz C, Tang MX, Luchsinger J, Mayeux R. Relation of plasma lipids to alzheimer's disease and vascular dementia. Arch Neurol. 2004; 61:705-714.
11. Mielke MM, Zandi PP, Sjogren M, et al. High total cholesterol levels in late life associated with a reduced risk of dementia. Neurology. 2005;64:1689-1695.
12. Notkola IL, Sulkava R, Pekkanen J, et al. Serum total cholesterol, apo-lipoprotein e epsilon 4 allele, and alzheimer's disease. Neuroepidemi-ology. 1998;17:14-20.
13. Solomon A, Kareholt I, Ngandu BM, et al. Serum cholesterol changes after midlife and late life cognition. Twenty-one-year follow-up study. Neurology. 2007;68:751-756.
14. Stewart R, White LR, Xue QL, Launer LJ. Twenty-six-year change in total cholesterol levels and incident dementia. Arch Neurol. 2007; 64:103-107.
15. Lesser G, Kandiah K, Libow LS, et al. Elevated serum total cholesterol and LDL cholesterol in very old patients with alzheimer's disease. Dement Geriatr Cogn Disord. 2001;12:138-145.
16. Lehtonen A, Luutonen S. High-density lipoprotein cholesterol levels of very old people in the diagnosis of dementia. Age Ageing. 1986; 15:267-270.
17. Moroney JT, Tang MX, Breglung L, et al. Low-density lipoprotein cholesterol and the risk of dementia with stroke. JAMA. 1999; 282:254-260.
18. Caramelli P, Nitrini R, Maranhao R, et al. Increased apolipoprotein B serum concentration in alzheimer's disease. Acta Neurol Scand. 1999; 100:61-63.
19. van Exel E, de Craen AJM, Gussekloo J, et al. Association between high-density-lipoprotein and cognitive impairment in the oldest old. Ann Neurol. 2002;51:716-721.
20. Saczynski JS, White L, Peila RL, Rodriguez BL, Launer LJ. The relationship between apolipoprotein a-i and dementia. The Honolulu-asia aging Study. Am J Epidemiol. 2007;165:985-992.
21. Muckle TJ, Roy JR. High-density lipoprotein cholesterol in differential diagnosis of senile dementia. Lancet. 1985;1:1191-1193.
22. Zuliani G, Blè A, Zanca R, et al. Lipoprotein profle in older patients with vascular dementia and alzheimer's disease. BMC Geriatr. 2001;1:5.
23. Bonarek M, Barberger-Gateau P, Letenneur L, et al. Relationship between cholesterol, Apolipoprotein e polymorphism and dementia: a cross-sectional analysis from the PaQUiD Study. Neuroepidemiology. 2000;19:141-148.
24. Kalman J, Kudchodkar BJ, Murray K, et al. Evaluation of serum-lipid-related cardiovascular risk factors in alzheimer's disease. Dement Geriatr Cogn Dis. 1999;10:488-493.
25. Launer LJ, White LR, Petrovitch H, Ross GW, Curb JD. Cholesterol and neuropathologic markers of aD: a population-based autopsy study. Neurology. 2002;57:1447-1452.
26. Ferrucci L, Bandinelli S, Benvenuti E, et al. For the inCHianti Group. Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the inCHianti study. J Am Geriatr Soc. 2000;48:1618-1625.
27. Cherubini A, Martin A, Andres-Lacueva C, et al. Vitamin e levels, Cognitive impairment and dementia in older persons: the inCHianti study. Neurobiol Aging. 2005;26:987-994.
28. Pisani P, Faggiano F, Krogh V, Palli D, Vineis P, Berrino F. Relative validity and reproducibility of a food frequency dietary questionnaire for use in the italian ePiC centres. Int J Epidemiol. 1997;26:152-160.
29. Bartali B, Turrini A, Salvini S, et al. Dietary intake estimated using different methods in two italian older populations. Arch Gerontol Geriatr. 2004;38:51-60.
30. Newman AB, Sutton-Tyrell K, Kuller LH. Lower-extremity arterial disease in older hypertensive adults. Arterioscler Thromb. 1993; 13:555-562.
31. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein e by gene amplifcation and cleavage with Hhai. J Lipid Res. 1990;31:545-548.
32. Assmann G, Schulte H, von Eckardstein A, et al. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCam experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis. 1996;Suppl:S11-S20.
33. Hofman A, Ott A, Breteler MM, et al. Atherosclerosis, Apolipoprotein E, and prevalence of dementia and alzheimer's disease in the Rotterdam Study. Lancet. 1997;349:151-154. (Pubitemid 27039193)
34. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markersbery WR. Brain infarction and the clinical expression of alzheimer's disease. The nun study, JAMA. 1997;277:813-817.
35. Zuliani G, Ranzini M, Guerra G, et al. Plasma cytokines profle in older subjects with late onset alzheimer's disease or vascular dementia. J Psychiatr Res. 2007;41:686-693.
36. Zuliani G, Volpato S, Blè A, et al. High interleukin-6 plasma levels are associated with low HDL-C levels in community dwelling older adults: the inChianti study. Atherosclerosis. 2007;192(2):384-390.
37. Verdery RB, Walford RL. Changes in plasma lipids and lipoproteins in human during a 2-year period of dietary restriction in biosphere 2. Arch Intern Med. 1998;158:900-906.
38. Zuliani G, Romagnoni F, Bollini C, Leoci V, Soattin L, Fellin R. Low levels of high-density lipoprotein cholesterol are a marker of disability in the elderly. Gerontology. 1999;45:317-322.
39. Lim PP, Sahadevan S, Choo GK, Anthony P. Burden of caregiving in mild to moderate dementia: an asian experience. Int Psychogeriatr. 1999;11:411-420.
40. Volpato S, Leveille SG, Corti MC, et al. The value of serum albumin and high-density lipoprotein cholesterol in defning mortality risk in older persons with low serum cholesterol. J Am Geriatr Soc. 2001;49:1142-1147.
41. Ruggiero C, Metter EJ, Melenovsky V, et al. High basal metabolic rate is a risk factor for mortality: the Baltimore Longitudinal Study of aging. J Geront Med Sci. 2008;63:698-706.